Extramedullary disease in multiple myeloma in the era of novel agents
False positive cervical smear in a patient with pernicious anaemia
Numerous Howell-Jolly bodies in a patient with idiopathic splenic calcification
Role of enhanced half-life factor VIII and IX in the treatment of haemophilia
The current status of prophylactic replacement therapy in children and adults with haemophilia
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma
MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity
Characterization of bone marrow mesenchymal stromal cells in aplastic anaemia
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas
JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms
Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide–bortezomib combinations
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation
The applicability of the WHO classification in paediatric AML. A NOPHO-AML study
CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants
Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia
Sex chromosome loss in adults with haematological neoplasms
Renal impairment at presentation in multiple myeloma continues to be associated with poor survival
Coagulation activation during air travel is not initiated via the extrinsic pathway
RAS mutation status and bortezomib therapy for relapsed multiple myeloma
Genetic susceptibility variants for chronic lymphocytic leukaemia in Mexican mestizos